Us Bancorp \De\ Myriad Genetics Inc Transaction History

Us Bancorp \De\

$78.3 Billion
Q2 2025

A detailed history of Us Bancorp \De\ transactions in Myriad Genetics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 2,620 shares of MYGN stock, worth $15,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,620

Previous 796 229.15%

Holding current value

$15,798

Previous $7,000 85.71%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	BUY	$3.84 - $8.84 $7,004 - $16,124	1,824 Added 229.15%	2,620 $13,000
Q1 2025 May 08, 2025	BUY	$8.87 - $14.98 $4,639 - $7,834	523 Added 191.58%	796 $7,000
Q4 2024 Feb 05, 2025	SELL	$13.17 - $27.03 $592 - $1,216	-45 Reduced 14.15%	273 $3,000
Q3 2024 Oct 28, 2024	SELL	$23.97 - $28.6 $5,033 - $6,006	-210 Reduced 39.77%	318 $8,000
Q2 2024 Aug 06, 2024	BUY	$17.98 - $25.47 $1,941 - $2,750	108 Added 25.71%	528 $12,000
Q4 2023 Feb 09, 2024	SELL	$13.91 - $21.32 $6,648 - $10,190	-478 Reduced 53.23%	420 $8,000
Q3 2023 Nov 03, 2023	SELL	$15.99 - $23.22 $1,519 - $2,205	-95 Reduced 9.57%	898 $14,000
Q2 2023 Aug 09, 2023	BUY	$17.56 - $23.76 $7,621 - $10,311	434 Added 77.64%	993 $23,000
Q1 2023 May 09, 2023	BUY	$15.26 - $23.75 $1,617 - $2,517	106 Added 23.4%	559 $12,000
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $43,080 - $62,319	-2,969 Reduced 86.76%	453 $6,000
Q3 2022 Oct 27, 2022	SELL	$18.21 - $27.88 $3,387 - $5,185	-186 Reduced 5.16%	3,422 $65,000
Q2 2022 Aug 01, 2022	SELL	$16.45 - $25.88 $10,445 - $16,433	-635 Reduced 14.97%	3,608 $66,000
Q1 2022 May 11, 2022	BUY	$22.67 - $28.01 $12,264 - $15,153	541 Added 14.61%	4,243 $108,000
Q4 2021 Feb 11, 2022	BUY	$24.13 - $32.63 $9,024 - $12,203	374 Added 11.24%	3,702 $102,000
Q3 2021 Nov 10, 2021	BUY	$29.97 - $36.66 $22,177 - $27,128	740 Added 28.59%	3,328 $108,000
Q2 2021 Aug 05, 2021	BUY	$25.39 - $32.61 $65,709 - $84,394	2,588 New	2,588 $79,000
Q3 2020 Nov 10, 2020	SELL	$11.25 - $14.75 $5,535 - $7,257	-492 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$10.69 - $16.49 $7,931 - $12,235	-742 Reduced 60.13%	492 $5,000
Q1 2020 May 13, 2020	BUY	$9.78 - $29.53 $9,349 - $28,230	956 Added 343.88%	1,234 $17,000
Q4 2019 Feb 04, 2020	SELL	$20.93 - $35.1 $586 - $982	-28 Reduced 9.15%	278 $8,000
Q3 2019 Nov 08, 2019	BUY	$22.08 - $47.08 $1,898 - $4,048	86 Added 39.09%	306 $9,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $11,040 - $17,045	-487 Reduced 68.88%	220 $6,000
Q1 2019 May 08, 2019	SELL	$26.93 - $34.7 $35,493 - $45,734	-1,318 Reduced 65.09%	707 $23,000
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $30,742 - $51,437	1,129 Added 126.0%	2,025 $59,000
Q3 2018 Nov 01, 2018	BUY	$37.57 - $50.34 $1,540 - $2,063	41 Added 4.8%	896 $41,000
Q1 2018 May 08, 2018	SELL	$28.83 - $41.01 $42,408 - $60,325	-1,471 Reduced 63.24%	855 $26,000
Q4 2017 Feb 02, 2018	BUY	$28.45 - $37.14 $1,109 - $1,448	39 Added 1.71%	2,326 $80,000
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $54,910 - $82,789	2,287	2,287 $82,000

Others Institutions Holding MYGN

# of Institutions

228

Shares Held

97.3M

Call Options Held

121K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $486M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account